SynerGene Therapeutics, Inc.
6 clinical trials · Sponsor
◉ Watch SynerGene Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| SGT-53 in Children With Recurrent or Progressive CNS Malignancies (NCT03554707) | SynerGene Therapeutics, Inc. | 2022-06-01 |
Track SynerGene Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.